Atul Ltd Q1 FY27 Results Analysis: Revenue Surges 25%, EBITDA Margin Expands 535 bps
Cofacto Research
Updated July 24, 2026
2 min read
Positive
Atul Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 1,847.95 Cr (+25.03% YoY) and PAT growth of +91.99% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | July 24, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 1,847.95 Cr (+25.03% YoY) |
|---|
| PAT (Q1) | Rs. 253.93 Cr (+91.99% YoY) |
|---|
| EBITDA margin | 21.41% (+535 bps YoY) |
|---|
| EPS (Q1) | Rs. 83.32 (+91.99% YoY) |
|---|
| Market cap | Rs. 18,854.81 Cr |
|---|
| CMP | Rs. 6,407.50 |
|---|
Quarter Snapshot
Atul delivered a record quarter with 25% revenue growth and 535 bps EBITDA margin expansion, driven by strong performance in the Performance & Other Chemicals segment and operating leverage. Cost discipline and forex tailwinds boosted earnings, but input cost pressures and inventory timing effects warrant monitoring. The company is on track to achieve its medium-term growth targets.
Key Investment Insights
Key Positives
- Consolidated revenue grew 25.0% YoY to Rs.1,847.95 cr, the highest quarterly revenue on record.
- EBITDA margin expanded 535 bps YoY to 21.41%, driven by cost discipline and operating leverage.
- POC segment revenue surged 33.8% YoY with EBIT margin expanding 743 bps to 16.80%.
- PAT grew 91.9% YoY to Rs.253.93 cr, with EPS of Rs.83.32 (up 92% YoY).
- Subsidiary contribution rose 47.4% YoY to Rs.44.27 cr, signaling strong performance from subsidiaries.
Risk Factors
- Cost of materials consumed grew 39.4% YoY, outpacing revenue growth, indicating input cost pressures.
- Large inventory drawdown of Rs.187.77 cr boosted margins but is a timing effect, not sustainable.
- Forex tailwind from weaker rupee may not persist, potentially impacting future export realisations.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now